Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today...
-
Recent BEAM-302 Topline Data in Alpha-1 Antitrypsin Deficiency (AATD) Demonstrate Strong Single-dose Safety and Efficacy Profile, with 60 mg Selected as Optimal Biological Dose; Global Pivotal Cohort...
-
First Quarter Total Revenue of $86.8 Million, an Increase of 5% Versus Prior Year. GAAP Net Income of $3.7 Million Versus Net Loss in Prior Year Period.
-
Fourth Quarter Sales Increased by 26% Year-over-Year to $243 MillionFiscal Year 2026 Sales Increased by 23% Year-over-Year to $890 Million MANCHESTER, N.H., May 07, 2026 (GLOBE NEWSWIRE) -- Allegro...
-
Total End of Period Subscribers of 2.7 million; End of Period Clinical Subscribers of 197 thousand, up 46% year-over-year Revenue of $168 million; Clinical Subscription Revenue of $39 million, up 32%...
-
BETHESDA, Md., May 07, 2026 (GLOBE NEWSWIRE) -- Liquidity Services (NASDAQ:LQDT; www.liquidityservices.com), the leading global provider of e-commerce marketplaces and software solutions powering...
-
Americold’s JV with EQT strengthens its balance sheet and expands flexibility to invest, supporting long‑term growth across its cold chain network.
-
Americold Announces First Quarter 2026 Results
-
Q1 2026 EPS Exceeded Guidance Range, Both Revenue and GM At the High End of Guidance Range Issued on February 12, 2026Company Q2 2026 Guidance: Revenues to Increase 10.0% to 13.0% QoQ, Gross Margin is...
-
ARHAUS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS